- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07942935
Novel Dietary Interventions in Functional Dyspepsia
This pilot study will test whether people with functional dyspepsia can follow two new dietary approaches and whether these diets may improve symptoms. Thirty adults will be randomly assigned to follow a low-histidine diet, a low-tryptophan diet, or a comparison diet for six weeks. The study aims to reduce-not eliminate- intake. The comparison diet provides dietary instructions that are not intended to reduce either nutrient.
The main goal is to determine whether participants intake of these nutrients can change through diet approaches.
Participants will receive nutrition counseling, follow the diet assigned, describe food consumption during dietary-recall interviews, complete questionnaires, provide blood and urine samples, and swallow a capsule that measures movement and gases in the digestive tract before and after the intervention.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: William Hirsch, MD
- Telefonnummer: 734-936-4998
- E-post: whirsch@med.umich.edu
Studiesteder
-
-
Michigan
-
Ann Arbor, Michigan, Forente stater, 48109
- University of Michigan
-
Ta kontakt med:
- William Hirsch, MD
- Telefonnummer: 734-936-4998
- E-post: whirsch@med.umich.edu
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- meeting Rome IV criteria for Functional dyspepsia (FD)
- planned esophagogastroduodenoscopy (EGD) as part of clinical care
Exclusion Criteria:
- Documented drug or alcohol use disorder
- Documented history of an eating disorder
- Habitual vegetarian or vegan diet
- Currently pregnant or breastfeeding or anticipating pregnancy during study period
- Unwilling to follow a low histidine or low tryptophan diet
- Unexplained weight loss, dysphagia, or other warning signs that would prompt evaluation with esophagogastroduodenoscopy - if present would need to ensure no evidence of Los Angeles (LA) grade C or D esophagitis or peptic ulcer disease on EGD performed as part of clinical care
- Use of daily opioid pain medication or glucagon-like peptide receptor 1(GLP-1) agonist
- Current use of metoclopramide or other prokinetic medication
- History of gastrointestinal surgery
- Poorly controlled diabetes mellitus (HgbA1c >10%)
- Known allergy to ingredient in Atmo Motility Bar (Rolled oats, glucose syrup, soy nuggets, rice bran crisps, brown rice syrup, pea protein powder, glycerine, natural vanilla extract and monkfruit juice extract)
- Inability to swallow pills the size of large vitamins
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: low histidine diet
Approximately 10 participants between the ages of 18-75 years old. |
Histamine and histidine are used interchangeably in study materials. Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce histidine intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6. |
|
Eksperimentell: low tryptophan diet
Approximately 10 participants between the ages of 18-75 years old. |
Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6. |
|
Placebo komparator: sham diet
Approximately 10 participants between the ages of 18-75 years old. |
Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary recommendations that will not lead to an impact in dietary histidine or tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in 24-hour dietary histidine
Tidsramme: baseline, 6 week
|
Histidine is assessed through 24-hour dietary recall using Nutrition Data System for Research (NDSR) |
baseline, 6 week
|
|
Change in 24-hour dietary tryptophan
Tidsramme: baseline, 6 week
|
Tryptophan is assessed through 24-hour dietary recall using NDSR |
baseline, 6 week
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of participants who meet a 30% reduction in dietary tryptophan
Tidsramme: 6 week
|
Tryptophan is assessed through 24-hour dietary recall using NDSR |
6 week
|
|
Percentage of participants who meet a 30% reduction in dietary histidine
Tidsramme: 6 week
|
Histidine is assessed through 24-hour dietary recall using NDSR |
6 week
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- HUM00294428
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .